The second of a series of three articles reports on a survey aimed at exploring the knowledge, perception and attitude of general practitioners towards generic medicines in Karachi, Pakistan [1].
Attitude of general practitioners towards generics in Pakistan
Generics/Research | Posted 24/08/2012 0 Post your comment
This exploratory, descriptive study was conducted on a sample of 289 randomly selected General Practitioners (GPs) who were dispensing at their private clinics in Karachi, Pakistan. The questionnaires were distributed and collected by hand. Statistical Package for Social Sciences (SPSS) version 17 was used to perform statistics. The first part of the survey collected demographic data about the doctors, the second part tested their basic understanding of generic versus brand medicines; the third part addressed GPs’ perceptions of generic medicines while lastly their attitude towards prescribing generic medicines was assessed. A response rate of 71.3% correctly filled in questionnaires was considered acceptable.
Statements testing basic understanding |
Correct answer n (%) |
Incorrect answer n (%) |
Generic medicines must be in the same dosage form such as tablet, capsule; as brand-name medicines | 156 (75.7) | 50 (24.3) |
Generic medicines are manufactured after the originator/innovator patent has expired | 88 (42.7) | 118 (57.3) |
Close to three quarters of respondents (n = 148; 71.8%) answered ‘yes’ that generic medicines are a copy of the brand name medicine and they are interchangeable with brand-name medicines.
Statements testing perceptions |
Agree n (%) |
Neutral n (%) |
Disagree n (%) |
I believe that multinational products are of better quality than local company products |
123 (59.7) |
49 (23.8) |
34 (16.5) |
I believe that not all the local companies in Pakistan are following Good Manufacturing Practices guidelines like multinationals |
111 (53.9) |
59 (28.6) |
36 (17.5) |
Fourteen statements were included on the views about safety, quality and efficacy of generic medicines and the reputation of local manufacturers and their low-cost brands. In terms of quality, more than half of the respondents viewed multinational products as being of better quality than local company products (n = 123; 59.7%) and this correlated significantly with gender (p = 0.034) and years of practice (p = 0.021).
Statements testing attitude |
Agree n (%) |
Neutral n (%) |
Disagree n (%) |
I wish to prescribe low cost medicines in my practice |
157 (76.2) |
20 (9.7) |
29 (14.1) |
I feel that medical representatives are a good source of information for me |
158 (76.6) |
24 (11.7) |
24 (11.7) |
Twelve statements assessed prescribing attitude in light of the socio-economic condition of the patient, patients’ demands, influence of medical representatives, as well as quality in local manufacturers’ brands. Information provided by a medical representative and doctors’ own experience in practice were rated highly.
Conclusion
General Practitioners are pulled in different directions by a desire to help the less affluent patients, the theoretical knowledge that generics are equivalent, but practical experience that local brands may not be of such good quality as international brands.
Related articles
Misunderstandings regarding generics in Pakistan
Compliance with generic drug use among Pakistani immigrants
Perception of generic drugs as fake among Pakistani immigrants
Pakistani immigrants may confuse generics with counterfeit drugs
References
1. Jamshed SQ, Ibrahim MIM, Hassali MA, Masood I, Low BY, Shafie AA, et al. Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: a questionnaire based study. Southern Med Review. 2012;5(1):22-30.
Most viewed articles
The best selling biotechnology drugs of 2008: the next biosimilars targets
Global biosimilars guideline development – EGA’s perspective
Related content
Japan’s drug shortage crisis: challenges and policy solutions
Saudi FDA drug approvals and GMP inspections: trend analysis
Generic medications in the Lebanese community: understanding and public perception
Community pharmacists’ understanding of generic and biosimilar drugs: Lebanon case study
Comments (0)
Post your comment